Gradient-echo magnetic resonance imaging study of pancreatic iron overload in young Egyptian beta-thalassemia major patients and effect of splenectomy

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Matter, Randa M ^a   Allam, Khalid E ^a   Sadony, Amany M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; DEFEROXAMINE MESYLATE; FERRITIN; GLUCOSE; INSULIN; IRON;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; CALCULATION; CHELATION THERAPY; CHILD; CHILDHOOD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE COURSE; EGYPT; EQUIPMENT; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLUCOSE TOLERANCE; HEMATOLOGY; HUMAN; LABORATORY TEST; LIVER; LIVER FUNCTION TEST; LIVER HEMOSIDEROSIS; MALE; NOISE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; PANCREAS DISEASE; PANCREATIC IRON OVERLOAD; PANCREATIC SIDEROSIS; PEDIATRIC HOSPITAL; POPULATION; PRIORITY JOURNAL; SIDEROSIS; SPLENECTOMY; THALASSEMIA MAJOR; THERAPY EFFECT;

EID: 77953448067     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-23     Document Type: Article

References (36)

1. Morphologic and Functional evaluation of the exocrine pancreas in beta-thalassemia major. L Gullo E Corcioni C Brancati M Bria R Pezzilli G Sprovieri, Pancreas 1993 8 2 176 80 10.1097/00006676-199303000-00007 8460093
2. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. C Kattamis V Ladis D Tsoussis I Kaloumenou C Theodoridis, Pediatr Endocrinol Rev 2004 2 Suppl 2 267 271 16462709
3. Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study. CK Li CW Luk SC Ling KW Chik HL Yuen CK Li MM Shing KO Chang PM Yuen, Hong Kong Med J 2002 8 4 255 60 12167729
4. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). V De Sanctis A Eleftheriou C Malaventura, Pediatr Endocrinol Rev 2004 2 Suppl 2 249 55 16462705
5. Insulin sensitivity and beta cell secretion in thalassaemia major with secondary hemochromatosis: assessment by oral glucose tolerance test. H Cario RW Holl M Debatin E Kohne, Eur J Pediatr 2003 162 3 139 46 12655415
6. Ultrasonography as a function index, in children with beta-thalassemia. M Theochari D Ioannidou H Nounopoulos A Bouloukos M Papadogiannis M Katsikari T Karpathios CS Bartsocas, J Pediatr Endocrinol Metab 2000 13 3 303 306 10714756
7. Hepatic iron overload: diagnosis and quantification with MR imaging. O Ernst G Sergent P Bonvarlet V Canva Delcambre JC Paris C L'Hermine, AJR Am J Roentgenol 1997 168 5 1205 8 9129412
8. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. E Alexopoulou F Stripeli P Baras I Seimenis A Kattamis V Ladis E Efstathopoulos EN Brountzos AD Kelekis NL Kelekis, J Magn Reson Imaging 2006 23 2 163 70 10.1002/jmri.20489 16374880
9. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. A Christoforidis A Haritandi I Tsitouridis I Tsatra H Tsantali S Karyda AS Dimitriadis M Athanassiou-Metaxa, J Pediatr Hematol Oncol 2006 28 5 311 5 10.1097/01.mph. 0000212915.22265.3b 16772883
10. Magnetic resonance imaging measurement of iron overload. JC Wood, Curr Opin Hematol 2007 14 3 183 190 10.1097/MOH.0b013e3280d2b76b 17414205
11. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. M Midiri A Lo Casto G Sparacia P D'Angelo R Malizia M Finazzo G Montalto L Solbiati R Lagalla M De Maria, AJR Am J Roentgenol 1999 173 1 187 92 10397124
12. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. MI Argyropoulou DN Kiortsis L Astrakas Z Metafratzi N Chalissos SC Efremidis, Eur Radiol 2007 17 12 3025 30 10.1007/s00330-007-0683-1 17549485
13. The pancreas in beta-thalassaemia major: MR Imaging features and correlation with iron stores and glucose disturbances. O Papakonstantinou V Ladis S Kostaridou T Maris H Berdousi C Kattamis N Gourtsoyiannis, Eur Radiol 2007 17 6 1535 43 10.1007/s00330-006-0507-8 17149622
14. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, WHO/NCD/NCS/99.2. Geneva. Ref Type: Report 1999
15. Non-invasive assessment of hepatic iron stores by MRI. Y Gandon D Olivié D Guyader C Aubé F Oberti V Sebille Y Deugnier, Lancet 2004 363 9406 357 62 10.1016/S0140-6736(04)15436-6 15070565
16. Hepatic iron concentration: Non invasive estimation by means of MR imaging techniques. HL Bonkovsky RB Rubin EE Cable A Davidoff TH Rijcken DD Stark, Radiology 1999 212 1 227 34 10405746
17. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital. CK Ong SL Lim WC Tan EE Ong AS Goh, Med J Malaysia 2008 63 2 109 12 18942294
18. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. MR Gamberini V De Sanctis G Gilli, Pediatr Endocrinol Rev 2008 6 Suppl 1 158 69 19337172
19. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors. M Hafez I Youssry FA El-Hamed A Ibrahim, Hemoglobin 2009 33 2 101 8 10.1080/03630260902817131 19373585
20. Abnormal glucose tolerance in Egyptian Beta thalassemic patients: possible association with genotyping. AS Khalifa M Salem E Mounir MM El-Tawil M El Sawy MM Abd Al-Aziz, Pediatr Diabetes 2004 5 3 126 32 10.1111/j.1399-543X. 2004.00051.x 15450007
21. Abnormal Glucose tolerance in transfusion-dependant beta-thalassemic patients. JP Chern KH Lin MY Lu DT Lin KS Lin JD Chen CC Fu, Diabetes Care 2001 24 5 850 4 10.2337/diacare.24.5.850 11347742
22. Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. K Farmaki N Angelopoulos G Anagnostopoulos E Gotsis G Rombopoulos G Tolis, Br J Haematol 2006 134 4 438 44 10.1111/j.1365-2141.2006.06203.x 16822284
23. Comparison between signal to noise ratio, liver-to-muscle ratio, and 1/T2 for the noninvasive assessment of liver iron content by MRI. A Fenzi M Bortolazzi P Marzola, J Magn Reson Imaging 2003 17 5 589 592 10.1002/jmri.10306 12720269
24. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Y Gandon D Guyader JF Heautot MI Reda J Yaouanq T Buhé P Brissot M Carsin Y Deugnier, Radiology 1994 193 2 533 8 7972774
25. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. WY Au WW Lam W Chu S Tam WK Wong R Liang SY Ha, Hematologica 2008 93 1 116 119 10.3324/haematol.11768 (Pubitemid 351156159)
26. Magnetic resonance screening of iron status in transfusion-dependent- thalassaemia patients. GC Ooi PL Khong GC Chan KN Chan KL Chan W Lam I Ng SY Ha, Br J Haematol 2004 124 3 385 90 10.1046/j.1365-2141.2003.04772.x 14717788
27. A cross-sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. WY Au WW Lam WW Chu HL Yuen AS Ling RC Li HM Chan HK Lee MF Law HS Liu R Liang SY Ha, Haematologica 2008 93 5 784 6 10.3324/haematol.12367 18450735
28. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. LJ Noetzli J Papudesi TD Coates JC Wood, Blood 2009 114 19 4021 6 10.1182/blood-2009-06-225615 19726718
29. The possible role of autoimmunity in the pathogenesis of diabetes in B-thalassemia major. L Monge S Pinach L Caramellino MT Bertero A Dall'omo Q Carta, Diabetes Metab 2001 27 2 pt 1 149 54 11353881
30. Endocrine abnormalities in thalassemia. C Vullo V De Sanctis M Katz B Wonke AV Hoffbrand B Bagni T Torresani G Tolis M Masiero A Di Palma L Borgatti, Ann N Y Acad Sci 1999 612 293 310 10.1111/j.1749-6632.1990.tb24317.x
31. MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. A Christoforidis V Perifanis G Spanos E Vlachaki M Economou I Tsatra M Athanassiou-Metaxa, Eur J Haematol 2009 82 5 388 92 10.1111/j.1600-0609.2009.01223.x 19141120
32. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. AW Leung WC Chu WW Lam V Lee CK Li, Pediatr Blood Cancer 2009 53 6 1054 9 10.1002/pbc.22170 19618454
33. MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? MI Argyropoulou DN Kiortsis SC Efremidis, Eur Radiol 2003 13 1 12 16 12541105
34. Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major. CJ Brewer TD Coates JC Wood, J Magn Reson Imaging 2009 29 2 357 64 10.1002/jmri.21666 19161188
35. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major. O Papakonstantinou E Alexopoulou N Economopoulos O Benekos A Kattamis S Kostaridou V Ladis E Efstathopoulos A Gouliamos NL Kelekis, J Magn Reson Imaging 2009 29 4 853 9 10.1002/jmri.21707 19306409
36. Thalassemia. HM Yaish, 2007 http://www.emedicine.com